Form 4: Cutera Director Kevin J. Cameron Reprices Stock Options

Sentiment:

SEC Form 4


Director Kevin J. Cameron repriced stock options at Cutera, Inc. on July 15, 2024, lowering the exercise price to $1.54 per share.

Summary

  • On July 15, 2024, Kevin J. Cameron, a director at Cutera, Inc., had his stock options repriced by the Issuer's Board of Directors.
  • The exercise price of the options was lowered to $1.54 per share from $16.84 per share.
  • Cameron acquired 25,327 options at the new price.
  • One-third of the shares subject to the option vested on May 19, 2024, and one-third will vest each year thereafter, contingent on continued service.
  • The options expire on May 19, 2030.
  • Following the repricing, Cameron beneficially owns 25,327 derivative securities.

Sentiment

Score: 5

Explanation: The document itself is neutral, simply reporting a transaction. The sentiment depends on the context of why the options were repriced. If the stock price is down, it could be seen as a negative, but the repricing itself is a tool to incentivize management, which could be viewed positively.

Positives

  • The repricing of stock options may incentivize the director to improve company performance.

Industry Context

Stock option repricing is a tool companies use to re-incentivize employees or directors when the stock price has fallen significantly below the original option exercise price. It's a common practice, especially in volatile markets, to retain and motivate key personnel.

Comparison to Industry Standards

  • Stock option repricing is a relatively common practice in the technology and biotech industries, especially when a company's stock price has declined significantly.
  • Companies like Zynerba Pharmaceuticals and others have used similar strategies to retain and incentivize key employees and directors.
  • The specific terms of the repricing, such as the new exercise price and vesting schedule, are typically tailored to the individual circumstances of the company and the employee or director involved.

Stakeholder Impact

  • Shareholders may view the repricing as a positive or negative signal depending on the company's performance and the reasons for the repricing.
  • The director is incentivized to improve company performance to increase the value of the options.

Key Dates

DateDescription
05/19/2024One-third of the shares subject to the option vested.
07/15/2024Date of stock option repricing.
07/17/2024Date of signature on the form.
05/19/2030Expiration date of the stock options.

Keywords

stock options, Cutera, director, repricing, Cameron, CUTR, options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.